Roche

Roche

Organization

Heard in 31 episodes across 17 shows since Jan 2026

Roche is a Swiss multinational healthcare company operating through Pharmaceuticals and Diagnostics divisions. It develops and commercializes medicines—particularly in oncology, immunology, neuroscience and other specialty areas—and diagnostic tests and technologies; the podcast references primarily concern its pharmaceutical pipeline, licensing and acquisitions, including China partnerships and metabolic-disease programs.

Discussed inMarkets62%AI & Tech15%Politics15%Culture8%

Episodes

31
across 17 shows

This week

0
episodes on 0 shows

Expert statements

2
2 positive

Share of the conversation

Mentions of Roche per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 24Sep 15Oct 8Oct 30Nov 21
Show the data
DayShare (7-day)Mentions
Aug 280.01‰1
Sep 140.01‰1
Sep 220.03‰3
Sep 230.04‰1
Oct 40.01‰1
Oct 190.01‰1
Oct 200.04‰4
Oct 260.04‰1
Oct 270.02‰1
Oct 280.03‰2
Oct 300.05‰2
Nov 90.01‰1
Nov 110.02‰1
Nov 140.02‰1
Nov 170.05‰4

The full trend: rank, tone and why it is trending →

Email alert

Email me when Roche comes up on a podcast

One email a week at most, with the new episodes that mention Roche. Free, no account needed, unsubscribe in one click.

What experts have said about Roche

2 statements · 2 positive

  1. Andrew JosephPositiveOct 30, 2026· The Readout Loud

    Roche's Devaracib reduced death risk 44% and progression risk 42% versus older KRAS inhibitors.

    “Devaracib outperformed them. It cut the risk of death by 44% and cut the risk of progression by 42%.”

    Listen at 10:55

    Open the episode · 419: Assessing Merck and Moderna's mRNA cancer vaccine
  2. Andrew JosephPositiveOct 30, 2026· The Readout Loud

    Devaracib will become standard of care in second-line treatment.

    “this will become standard of care in this second line setting.”

    Listen at 11:11

    Open the episode · 419: Assessing Merck and Moderna's mRNA cancer vaccine

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

31 episodes featuring Roche, newest first